Review outlines diagnostic criteria and molecular risk stratification in pediatric Wilms tumor, highlighting tailored therapeutic approaches to optimize patient outcomes.
Although Wilms tumor is the most common malignant renal tumor of childhood, it is an overall rare malignancy with a variety of histological appearances. As clinical trials have sought to further identify groups of patients who can benefit from escalation or de-escalation of therapy, an increasing number of histopathological and molecular factors have become important factors in patient risk stratification. This manuscript reviews the clinical presentation and typical histologic findings in Wilms tumor. The differential diagnostic considerations are explored, with practical recommendations for immunohistochemical and molecular workup to aid in accurate diagnosis. Finally, important known and emerging elements relevant to risk stratification are outlined, including pre- and post-therapy histological classification, staging, and important molecular findings.
No takes yet. Share an insight, caveat, or question.
Parsons et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: